The Department of Health and Human Services (HHS) announced today the award of contracts totaling $55.3 million to four companies for the advanced development of anthrax antitoxins, therapeutics and antibiotics for use against plague and tularemia.
HHS Awards Contracts for Advanced Development of New Medical Cou...Courtesy HHS News and Events Fri, 10/05/2007 - 16:00
The Department of Health and Human Services (HHS) announced today the award of contracts totaling $55.3 million to four companies for the advanced development of anthrax antitoxins, therapeutics and antibiotics for use against plague and tularemia. Sponsors
Tags:
Related itemsHospitals in Louisiana and Mississippi to Receive More Katrina R...
HHS Partners with Ohio and Pennsylvania to Raise Awareness on Pl...
HHS Secretary Leavitt Announces Members of the New Interagency A...
HHS Purchases Additional Anthrax Vaccine For Stockpile
UT Southwestern researchers uncover molecule that keeps pathogen...
|
Popular by tags WeekMonth |
Post new comment